Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Export of vital medical equipment to Russia partially restored

Exports of essential medical devices to Russia have been partly restored, reducing the immediate risk of life-threatening shortages after a near-total collapse, a Western...

AbbVie ends collaboration with BioArctic on alpha-synuclein portfolio

BioArctic AB (publ) has announced that the company's partner AbbVie has decided to terminate its collaboration with BioArctic regarding the portfolio of alpha-synuclein antibodies,...

FDA postpones approval of Teva’s schizophrenia drug

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the U.S. Food and Drug Administration (“FDA”) has issued a...

BioXcel Therapeutics raises funding from Oaktree Capital, Qatar’s Investment Authority

BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,  April 19th announced strategic financing...

J&J settles West Virginia opioid lawsuit for $99 million

Johnson & Johnson said on Monday it agreed to pay $99 million to settle claims by West Virginia that it helped fuel an opioid...

Nektar Therapeutics and Bristol Myers Squibb stop clinical trials for key cancer drug

Nektar Therapeutics and Bristol Myers Squibb announced that based on results from pre-planned analyses of two late-stage clinical studies of bempegaldesleukin (BEMPEG) in combination...
spot_img

Expert Articles

spot_img